Bain Capital Life Sciences Fund II, L.P. 13D and 13G filings for Savara Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-27 5:40 pm Purchase |
2025-03-25 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 17,600,621 9.990% |
3,035,164 (+20.84%) |
Filing |
| 2024-04-12 5:26 pm Purchase |
2024-04-10 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 14,565,457 13.000% |
332,706 (+2.34%) |
Filing |
| 2023-07-19 4:30 pm Purchase |
2023-07-17 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 14,232,751 13.000% |
2,610,153 (+22.46%) |
Filing |
| 2021-03-17 4:15 pm Purchase |
2021-03-15 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 11,622,598 13.000% |
6,494,005 (+126.62%) |
Filing |